Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4313-56-8

Post Buying Request

4313-56-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4313-56-8 Usage

Uses

(1-?Aminocyclohexyl)?methanol is used in the synthesis of Fsp3-rich, bis-spirocyclic-based compound libraries.

Check Digit Verification of cas no

The CAS Registry Mumber 4313-56-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4313-56:
(6*4)+(5*3)+(4*1)+(3*3)+(2*5)+(1*6)=68
68 % 10 = 8
So 4313-56-8 is a valid CAS Registry Number.

4313-56-8Relevant articles and documents

CYCLIN-DEPENDENT KINASE INHIBITING COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS

-

Page/Page column 172; 196, (2021/11/26)

This invention is in the area of cell cycle inhibiting compounds for the treatment of disorders involving abnormal cellular proliferation, and include selective CDK2 inhibitors for medical therapy and their pharmaceutically acceptable salts and compositions.

PYRIMIDINE-BASED ANTIPROLIFERATIVE AGENTS

-

Page/Page column 172; 190; 191, (2018/02/28)

This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

TRICYCLIC LACTAMS FOR USE IN THE PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY

-

Page/Page column 119-120, (2015/11/09)

This invention is in the area of tricyclic lactam compounds, compositions and methods of protecting healthy cells, and in particular hematopoietic stem and progenitor cells (HSPC) as well as renal cells, from damage associated with DNA damaging chemotherapeutic agents. In one aspect, protection of healthy cells is disclosed using compounds that act as cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors when administered to subjects undergoing DNA damaging chemotherapeutic regimens for the treatment of proliferative disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4313-56-8